Currently holds a position at Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Independent Director | Apellis Pharmaceuticals Inc | March 1, 2010 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-20 | 2024-03-19 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
18,681
-9.7%
57.181,068,161 USD |
18,681 -9.7% | 57.18 | 1,068,161 USD | |
2023-11-21 | 2023-11-17 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
8,894
-6.8%
49.99444,620 USD |
8,894 -6.8% | 49.99 | 444,620 USD | |
2023-11-21 | 2023-10-17 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
24,000
-10.0%
49.001,176,000 USD |
24,000 -10.0% | 49.00 | 1,176,000 USD | |
2023-03-02 | 2023-03-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
500
-0.4%
65.3332,665 USD |
500 -0.4% | 65.33 | 32,665 USD | |
2023-02-02 | 2023-02-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
500
-0.4%
52.6126,305 USD |
500 -0.4% | 52.61 | 26,305 USD | |
2023-01-05 | 2023-01-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
500
-0.4%
50.7025,350 USD |
500 -0.4% | 50.70 | 25,350 USD | |
2022-12-02 | 2022-12-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
500
-0.4%
49.9324,965 USD |
500 -0.4% | 49.93 | 24,965 USD | |
2022-11-03 | 2022-11-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
500
-0.4%
60.8330,415 USD |
500 -0.4% | 60.83 | 30,415 USD | |
2022-09-08 | 2022-09-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
15,000
-5.9%
65.00975,000 USD |
15,000 -5.9% | 65.00 | 975,000 USD | |
2022-08-12 | 2022-08-11 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
30,000
-10.5%
65.631,968,900 USD |
30,000 -10.5% | 65.63 | 1,968,900 USD | |
2022-06-24 | 2022-06-23 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
15,000
-5.0%
45.00675,000 USD |
15,000 -5.0% | 45.00 | 675,000 USD | |
2021-05-20 | 2021-05-20 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
5,773
-15.3%
48.10277,681 USD |
5,773 -15.3% | 48.10 | 277,681 USD | |
2021-05-20 | 2021-05-19 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
7,612
-2.5%
50.00380,600 USD |
7,612 -2.5% | 50.00 | 380,600 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
800
-0.3%
54.0243,216 USD |
800 -0.3% | 54.02 | 43,216 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
10,388
-3.3%
53.50555,758 USD |
10,388 -3.3% | 53.50 | 555,758 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
1,200
-0.4%
52.0162,412 USD |
1,200 -0.4% | 52.01 | 62,412 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
22,318
-37.2%
54.571,217,893 USD |
22,318 -37.2% | 54.57 | 1,217,893 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
36,387
-37.8%
53.781,956,893 USD |
36,387 -37.8% | 53.78 | 1,956,893 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
14,216
-12.9%
52.63748,188 USD |
14,216 -12.9% | 52.63 | 748,188 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
64,179
-36.7%
51.663,315,487 USD |
64,179 -36.7% | 51.66 | 3,315,487 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
214
-0.1%
56.2512,038 USD |
214 -0.1% | 56.25 | 12,038 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
17,132
-8.9%
55.01942,431 USD |
17,132 -8.9% | 55.01 | 942,431 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
7,654
-3.8%
53.86412,244 USD |
7,654 -3.8% | 53.86 | 412,244 USD | |
2020-12-07 | 2020-12-07 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
9,470
-4.5%
51.00482,970 USD |
9,470 -4.5% | 51.00 | 482,970 USD | |
2020-12-07 | 2020-12-07 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
9,094
-4.2%
50.41458,429 USD |
9,094 -4.2% | 50.41 | 458,429 USD | |
2020-12-07 | 2020-12-04 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
1,384
-0.6%
51.0570,653 USD |
1,384 -0.6% | 51.05 | 70,653 USD | |
2020-12-07 | 2020-12-04 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
5,052
-2.2%
50.04252,802 USD |
5,052 -2.2% | 50.04 | 252,802 USD |